Biotech

SPDR(R) S&P(R) Biotech ETF

$79.19

-9.7% last 12 months

Compare similar ETFs

Fund Size
Dividend
Fees
Current
(R) S&P(R) Biotech ETF XBI
Fund Size
$7.16 Billion
Dividend
0.0%
Fees
0.35%
Biotechnology ETF IBB
Fund Size
$8.44 Billion
Dividend
0.3%
Fees
0.44%
ARK Genomic Revolution ETF ARKG
Fund Size
$2.5 Billion
Dividend
0.0%
Fees
0.75%
NYSE Arca Biotechnology Index Fund FBT
Fund Size
$1.42 Billion
Dividend
0.0%
Fees
-
Biotechnology & Genome ETF PBE
Fund Size
$302 Million
Dividend
0.0%
Fees
-
View 7 similar ETFs →

Average metrics of all companies in portfolio

Compare to
Market
Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $11.9 Billion
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. 0.23 %
Beta Indicates the relationship between the price performance of a share and the market. 0.9324
P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. 32.47
Negative P/E Ratio a negative P/E ratio shows that the company is not profitable, and it shows how many years it would take the company to lose its entire market capitalisation if it did not change anything -9.72
Profitable Companies 15
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. 68.86
Price to Sales Ratio Market cap divided by the revenue in the most recent year. 9.22
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company 3.72
Compare to
Market
Enterprise Value to EBIT Enterprise Value divided by EBIT -2.32
Enterprise Value to Revenue Enterprise value divided by revenue 91.58
Total Debt to Enterprise Value Total debt divided by enterprise value 0.53
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. 0.271
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. -3180.97%
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. -
Return on Equity Equity divided by market cap. -29.89%
Return on Assets Indicates a company's profitability in relation to its total assets. -24.78%
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. -30.01%

Industries

Healthcare 88.9%
Other 4.9%
N/A 6.3%

Market cap

Micro Cap 8%
Small Cap 40%
Mid Cap 28%
Large Cap 22%
Mega Cap 1%

144 Investments

P/E-Ratio
Total Investment
Weight
State Street Global Advisors logo

MDY

State Street Global Advisors

P/E-Ratio
0.0
Total Investment
$634 Million
Weight
9.7%
Catalyst Pharmaceuticals Inc logo

CPRX - Manufacturing

Catalyst Pharmaceuticals Inc

P/E-Ratio
24.8
Total Investment
$82.9 Million
Weight
1.3%
Blueprint Medicines Corp logo

BPMC - Manufacturing

Blueprint Medicines Corp

P/E-Ratio
-7.6
Total Investment
$77.5 Million
Weight
1.2%
Bridgebio Pharma Inc logo

BBIO - Manufacturing

Bridgebio Pharma Inc

P/E-Ratio
-8.2
Total Investment
$77.1 Million
Weight
1.2%
Exact Sciences Corp logo

EXAS - Professional, Scientific, and Technical Services

Exact Sciences Corp

P/E-Ratio
-41.0
Total Investment
$76.7 Million
Weight
1.2%
Halozyme Therapeutics Inc logo

HALO - Manufacturing

Halozyme Therapeutics Inc

P/E-Ratio
20.1
Total Investment
$76.1 Million
Weight
1.2%
Vertex Pharmaceuticals Inc logo

VRTX - Manufacturing

Vertex Pharmaceuticals Inc

P/E-Ratio
26.4
Total Investment
$75.5 Million
Weight
1.2%
REVOLUTION Medicines Inc logo

RVMD - Manufacturing

REVOLUTION Medicines Inc

P/E-Ratio
-11.5
Total Investment
$75 Million
Weight
1.2%
Horizon Therapeutics Plc logo

HZNP - Manufacturing

Horizon Therapeutics Plc

P/E-Ratio
0.0
Total Investment
$74.3 Million
Weight
1.1%
IVERIC bio Inc logo

ISEE - Manufacturing

IVERIC bio Inc

P/E-Ratio
0.0
Total Investment
$74 Million
Weight
1.1%
Incyte Corp logo

INCY - Professional, Scientific, and Technical Services

Incyte Corp

P/E-Ratio
28.7
Total Investment
$73.1 Million
Weight
1.1%
Twist Bioscience Corp logo

TWST - Professional, Scientific, and Technical Services

Twist Bioscience Corp

P/E-Ratio
-6.8
Total Investment
$73.1 Million
Weight
1.1%
Amgen Inc logo

AMGN - Manufacturing

Amgen Inc

P/E-Ratio
19.1
Total Investment
$72.8 Million
Weight
1.1%
Apellis Pharmaceuticals Inc logo

APLS - Manufacturing

Apellis Pharmaceuticals Inc

P/E-Ratio
0.0
Total Investment
$72.6 Million
Weight
1.1%
Neurocrine Biosciences Inc logo

NBIX - Manufacturing

Neurocrine Biosciences Inc

P/E-Ratio
60.0
Total Investment
$72.4 Million
Weight
1.1%
Arrowhead Pharmaceuticals Inc logo

ARWR - Manufacturing

Arrowhead Pharmaceuticals Inc

P/E-Ratio
-12.6
Total Investment
$72.4 Million
Weight
1.1%
Ionis Pharmaceuticals Inc logo

IONS - Manufacturing

Ionis Pharmaceuticals Inc

P/E-Ratio
-17.3
Total Investment
$72.4 Million
Weight
1.1%
Natera Inc logo

NTRA - Health Care and Social Assistance

Natera Inc

P/E-Ratio
-13.5
Total Investment
$72.1 Million
Weight
1.1%
Alkermes PLC logo

Alkermes PLC

P/E-Ratio
n/a
Total Investment
$72.1 Million
Weight
1.1%
Alnylam Pharmaceuticals Inc logo

ALNY - Manufacturing

Alnylam Pharmaceuticals Inc

P/E-Ratio
-41.4
Total Investment
$71.4 Million
Weight
1.1%
Exelixis Inc logo

EXEL - Professional, Scientific, and Technical Services

Exelixis Inc

P/E-Ratio
73.7
Total Investment
$71.4 Million
Weight
1.1%
Novavax Inc logo

NVAX - Manufacturing

Novavax Inc

P/E-Ratio
-1.2
Total Investment
$71.3 Million
Weight
1.1%
Beam Therapeutics Inc logo

BEAM - Manufacturing

Beam Therapeutics Inc

P/E-Ratio
-7.3
Total Investment
$71.1 Million
Weight
1.1%
Vaxcyte Inc logo

PCVX - Manufacturing

Vaxcyte Inc

P/E-Ratio
0.0
Total Investment
$70.8 Million
Weight
1.1%
Gilead Sciences Inc logo

GILD - Manufacturing

Gilead Sciences Inc

P/E-Ratio
16.2
Total Investment
$70.7 Million
Weight
1.1%